AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Cheom-Gil Cheong

Examiner Cheom-Gil Cheong appears to be about average relative to their peer examiners. Their lifetime grant ratio is 50.5%, they average 1.96 office actions per granted patent, and their rejection profile leans toward §103 and elevated §112 usage.

Difficulty vs AU Very Easy
Difficulty vs Group About Average
Difficulty vs TC Very Easy
Difficulty vs USPTO About Average
Average OA / Grant 1.96
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
7 years (2020-2026)
Phone
(571) 272-6251
Predicted Supervisor
Gary Nickol
Supervisor Phone
(571) 272-0835
Tech Center
1600 - Biotechnology and Organic
Group
1640 - Immunology

Metrics

Applications Evaluated
200
Granted Applications
101
Non-Granted Applications
99
Avg OA / Grant
1.96
Last OA Observed
March 2026 (1 months ago)
Art Units Seen
1643 , 1645
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 50.5% 1.96
Art Unit 26 47.8% 2.04
Group 223 44.8% 1.94
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2020 2021 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2020; examiner may not yet have been active in the available dataset.
2020 20 15 75.0%
2021 25 14 56.0%
2022 33 26 78.8%
2023 34 19 55.9%
2024 31 18 58.1%
2025 36 9 25.0%
2026 21 0 0.0%

101 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 196 2.0% 13.3% 27.6% 15.8%
2 105 1.0% 5.7% 31.4% 28.6%
3 54 0.0% 7.4% 33.3% 25.9%
4 23 0.0% 8.7% 39.1% 21.7%
5 9 0.0% 0.0% 44.4% 22.2%
6 5 0.0% 0.0% 40.0% 40.0%
7 2 0.0% 0.0% 50.0% 50.0%
8 2 0.0% 0.0% 100.0% 0.0%
9 1 0.0% 0.0% 100.0% 0.0%
10 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
6.7%
2020
3.1%
2021
1.3%
2022
0.0%
2023
0.0%
2024
0.0%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.